23 April 2003
Anti-phospholipid antibodies and carotid-artery intima-media thickness in young survivors of myocardial infarction.
Jerzy Dropiński, Wojciech Szczeklik, Paweł Rubiś, Wojciech J. SydorMed Sci Monit 2003; 9(4): BR105-109 :: ID: 4708
Abstract
BACKGROUND: Not all coronary events occur in young individuals with traditional risk factors. In recent years some authors have observed increased prevalence of elevated anti-phospholipid (aPL) antibodies in young patients with myocardial infarction. Also, thickening of the combined arterial intima-media thickness (IMT) of superficial vessels has been identified as an independent risk factor for both stroke and heart attack. The objective of our study was to assess possible association between aPL antibodies and carotid IM thickening in young survivors of myocardial MATERIAL/METHODS: In a case control study we determined IgG and IgM antiphospholipid antibodies by enzyme-immunoassay, and IMT by ultrasonography in 50 male survivors of myocardial infarction under the age of 50, and compared them to 50 healthy controls. RESULTS: Elevated aPL antibody levels (IgG>10 GPL; IgM>20MPL) were detected in 12 of 50 patients (24%) with MI and in 3 of 50 controls (6%). The mean level of aPL antibodies was significantly higher in the patients than in the controls (IgG 9.15+/-3.53 vs 7.69+/-2.98 GMP, p=0.04 and IgM 18.46+/-7.61 vs 12.14+/-5.05 MPL, p<0.01). Patients with MI had a significantly greater IMT than healthy controls (0.9 mm vs 0.6 mm; p<0.01). There was a correlation between aPL and IM thickening (r=0.31; p=0.01). Among coronary risk factors only hypertension (r=0.28; p=0.01) and smoking (r=0.41; p=0.01) showed a relationship with IMT. CONCLUSIONS: The intima-media thickness of the carotid artery and elevated aPL antibodies are strongly associated with the risk of myocardial infarction in young patients.
Keywords: Antibodies, Antiphospholipid - blood, Myocardial Infarction - blood, Myocardial Infarction - ultrasonography, Tunica Intima - ultrasonography, Tunica Media - ultrasonography
492 4
Editorial
01 May 2023 : Editorial
Editorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor TherapyDOI: 10.12659/MSM.940911
Med Sci Monit 2023; 29:e940911
In Press
31 May 2023 : Review article
Prevalence, Diagnosis, and Management of Eclampsia and the Need for Improved Maternal Care: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.939919
30 May 2023 : Clinical Research
A Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodi...Med Sci Monit In Press; DOI: 10.12659/MSM.940409
30 May 2023 : Review article
A Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identif...Med Sci Monit In Press; DOI: 10.12659/MSM.940550
30 May 2023 : Database Analysis
The COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.940904
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952